Warner Brent 4
4 · Poseida Therapeutics, Inc. · Filed Mar 1, 2022
Insider Transaction Report
Form 4
Warner Brent
President, Gene Therapy
Transactions
- Award
Common Stock
2022-03-01+307,881→ 307,881 total - Award
Stock Option (Right to Buy)
2022-03-01+431,034→ 431,034 totalExercise: $3.42Exp: 2032-02-29→ Common Stock (431,034 underlying)
Footnotes (2)
- [F1]Represents shares issuable upon the vesting of restricted stock units granted pursuant to the Issuer's Inducement Plan. The RSUs are scheduled to vest in four equal annual installments.
- [F2]12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of the grant date listed in column 3 above, and the remaining shares will vest in 42 equal monthly installments thereafter.